Member Info for Indiscipline

Holders here know the plan and are seeing it executed. Buyers have found out the plan. This is a cornerstone investment for your portfoilio. CF is building up critical mass. This company has multiples that it can build into.

Having the worlds leading database for infectious disease alone means we are worth multiples of where we are in a comparatively short time. That will be further built on by CF size creates size. This company is becoming the equivalent of a SaaS for the pharma and healthcare sector.

The fact that he was taking stabs in the dark tells you about his style.

By this year he claimed previously before the broker change that he would not disagree with £20 mill in revenue hitting.
Then the trading update claimed that the big deal he announced after missed revenues was worth upto £10 million and in that company's interest to make it as high as possible". We had £150 grand in revenues in all deals.

The trade desk deal was a gamechanger. We got no revenue from it.

Maybe Fursake you are right. Because, maybe the rabbit got pulled out the hat and we have a surge. But also because he has not promoted the stock so less shareholders get hurt, if he fails. Come January we should have a much better idea.

The problem is he will need more funds and as we know more dilution. GFIN they seem to really be kicking on. Split your buys would be my view.

The real problem is that Draper has now ceased all contact with shareholders which means that there is total conjecture on all sides. The stock could be doing brilliantly, could be going badly.

Shareholders are owners of the company. They must be properly informed revenue wise. They are told it will be significantly above H1 but a more precise view needs to be given. Draper should not leave shareholders hanging.

It created a great base to spring from... CF is looking at this company as a blue chip with steroids. This is one you can put a healthy chunk of your portfolio in and look at it every six months to a year and be impressed with the growth.

He thinks he can double every year for the next few years. Considering the sector and its criminal underinvestment I believe him.

Unfortunately as an owner of one would have to agree with JH. Nas = biotech shorters paradise.

These guys are paid trolls. If you reply they make money.

Placing a downright lie means they get a reply so they make more money on the lie they generate. As we all know we need no cash. Cf has stated no raise ever again.

He knows and we know we are down as it has not been confirmed. Bottom line we jump again on contract confirmation.
The fact that we are talking of expanding facilities even more exciting. So much cash to bottom line.

It's been trading for months working this range. We may get a pullback to around 16p, if you are lucky using the old resistance
as support.

But this stock is seriously primed to go higher now - so buy in tranches and build your position that way. This way you get a blended price. We have not even priced the contract that was announced the day before.

CF building a cash machine.

Well done look forward to following your next pick. If this is type of investment you make. Congrats mate.

Link actually helped us average in at lower prices. Crazy to say this but they helped us all out.

Quick check on posting history shows one post per board on average and each a little troll remark.
Time to crawl back underground to troll master.

Congratulations on a sly troll post. Good to see one come in. Shows we are where the heat is at when this group emerge from the primordial swamp.

I doubt you were ever a shareholder.

If he was King, I would push for change from constitutional monarch to dictatorship.

Youtube Blue Skies - Frank Sinatra + Irving Berlin.

"Never saw the sun shining so bright,
Never saw things looking so right."

Blue skies above. Truly the breakthrough has occurred. No resistance and a large Impulse Candle.

From what I remember they went to 7.7% on the dilution. They have been good. They weren't the cause of our drop we all know the b'stards responsible.

Guys be a little more open. It's great to learn a new language. As that was all Chinese to me... or possibly Greek since we are talking medically.

erm you could be right...but...erm you could be erm wrong... the choice is erm ... in the erm ear of the beholder...

Still if she believes we are crazy under-valued I would agree with her. She sees we are de-risked with STEM and cash and now with Brazil trials underway she sees the catalysts as we have.

Obviously top secret project on behalf of our client. Great to see all the offices kicking in with multi million contracts.
All areas of the business delivering. £30 mil year end de-risking the price further.

Six months from now £40-£50 mil in cash which right now would have us at half our cap in cash. That is a cash generating machine. Most companies have 10-20% in cash. CF has turned this business around in a major major way.

This is before wearables and Imutex and PrepBiopharm have even been monetised. Got to give credit where its due.

Will not be long now before major rerate.

CF has already stated he is in the final stages of sourcing additional capacity. The raise ensured we had the money needed and that pot is projected to grow to around £30million by the end of the year. One third of our cap is cash by the end of the year on current projections.

This has been what CF has been planning for. Also our testing revs may start to kick in which is what he has alluded to.

Volatility will rush through the market. However, financial institutions must invest client capital in the right sector with a company with the right profile. If there is a drop like last time this will soon enough accelerate up for these reasons.

We are the stock for these times. Our profits are growing. Our services essential. Our products with Imutex and PrepBiopharm only further secure our price and the disparity between share price now and share price weeks from now.

In a bloody awful time this stock sits strongly in the current environment.

Was gonna say I see your ffs... and raise you three ffs's...
Then I thought the last thing I want mentioned is a raise...

I look at it this way. Right now we can chill. If you can top up along the way do so - as you pointed out we are nicey de-risked.

Stem and Covid results hitting before Xmas. They already have done masses of work on it already - with a top team.

The short weeks ahead the price can do anything. But with everything hitting now and company firmed up we are in a might better place than other pharma stocks. We are hitting market with products in a few short months...

Cerrone right definitely a year ahead of where we originally expected, with a supertanker of products coming down the pipe.